Resultado de búsqueda
Hace 2 días · Moreover, other potent acid-suppressive drugs, such as potassium-competitive acid blockers, may warrant further investigation in managing chronic cough. Conclusion.
Hace 4 días · This drug — a potassium-competitive acid blocker — is a potent inhibitor of the final step in gastric acid secretion and has some pharmacologic advantages over proton-pump inhibitors (PPIs): For example, it has a longer half-life than PPIs and does not require administration 30 to 60 minutes before eating for maximal effect.
Hace 4 días · Proton pump inhibitors (PPI) are commonly used drugs worldwide and have been linked to worsening renal function and incident chronic kidney disease. Recently, potassium-competitive acid blockers (P-CAB) have emerged as alternative gastric acid-reducing agents with a comparable effect as PPIs.
Hace 4 días · Efficacy and safety data of potassium-competitive acid blockers for the treatment of GERD and EE. Have greater competence related to. Selecting evidence-based treatment for patients with GERD and EE. Improved performance associated with identifying patients who require upper endoscopy for the differential diagnosis of EE.
Hace 5 días · Scarpignato C, et al. Editorial: towards extended acid suppression--the search continues. Aliment Pharmacol Ther. 2015;42:1027-1029. Abdel-Aziz Y, et al. Review article: potassium-competitive acid blockers for the treatment of acid-related disorders. Aliment Pharmacol Ther. 2021;53:794-809. Scott D, et al.
Hace 4 días · Lee Han-soo. Published 2024.05.23 17:47. Daewoong Pharmaceutical presented research on the efficacy of its potassium-competitive acid blocker (P-CAB) class gastroesophageal reflux disease (GERD) treatment, Fexuclue, at the Digestive Disease Week 2024 (DDW 2024) in Washington D.C., held from last Saturday to Tuesday.
Hace 4 días · Some [of these strategies] that have been explored and abandoned have included the potassium competitive-acid blockers and the potassium channel blockers, also called the PCABs.* [Other agents under investigation include] extended-release rabeprazole;* there is not a whole lot going on right now that I'm aware of as far as studies ...
